Yael Freiman

That is a rise of 12% since last year alone.

And overall, 124 million Americans are expected to see some sort of rate increase in their energy bill, according to a new report from Powerline.

So you just go across the board.

What are my monthly bills?

Child care, health care, food, groceries, electricity, everything's going up.

And that is feeding this sense that, you know, I'm just an average American.

I can't really afford life.

Welcome to Winners of the Weekend, the segment where Toby and I pick two things that have a lot to be thankful for.

I won the pre-show Wordle race, so I get to go first.

And my winner is Eli Lilly, because on Friday, it became the first healthcare company in the world to reach a market cap of $1 trillion.

Lilly's stock has been a rocket ship in the past few years because it makes the best-selling drug in the world, an injectable known as Zepbound or Monjaro that helps people lose loads of weight.

For a while, it was in a tight battle for GLP-1 supremacy with Danish rival Novo Nordisk, the maker of Ozempic and Wachovie, but recently it's left Novo in the dust thanks to more effective treatments and a savvier sales strategy.

Lilly was not an overnight success.

In fact, it was all the way back in 1876 when Civil War veteran Eli Lilly himself

opened a drugstore in Indianapolis that would later become a globe-spanning pharma giant with 50,000 employees worldwide.

Lilly has hit pay dirt with blockbuster drugs in the past, including the earliest polio vaccine, insulin and Prozac, but growth has gone into overdrive as it's dominated the weight loss revolution.

A lot of credit has to go to CEO Dave Ricks, who President Trump called one of the hottest people in the world of business, not about his looks, but about his ability to create shareholder value.

When Ricks joined in 2017, the company's market cap was $81 billion.

It's surged by more than $900 billion in value since then.

Toby, Lilly might be the most successful Hoosier since Larry Bird.